These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30049845)

  • 21. Potential role of ANGPTL4 in cancer progression, metastasis, and metabolism: a brief review.
    Park MS; Kim SE; Lee P; Lee JH; Jung KH; Hong SS
    BMB Rep; 2024 Aug; 57(8):343-351. PubMed ID: 39044455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TCCR/WSX-1 is a novel angiogenic factor in age-related macular degeneration.
    Sung HJ; Han JI; Lee JW; Uhm KB; Heo K
    Mol Vis; 2012; 18():234-40. PubMed ID: 22312192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aqueous Level of ANGPTL4 Correlates with the OCTA Metrics of Diabetic Macular Edema in NPDR.
    Xu Q; Gong C; Qiao L; Feng R; Liu H; Liu Y; Ji S; Zhang Y; Wu S; Li S
    J Diabetes Res; 2022; 2022():8435603. PubMed ID: 35097131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aqueous Angiopoietin-Like 4 Levels Correlate With Nonperfusion Area and Macular Edema in Branch Retinal Vein Occlusion.
    Kim JH; Shin JP; Kim IT; Park DH
    Invest Ophthalmol Vis Sci; 2016 Jan; 57(1):6-11. PubMed ID: 26746013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiopoietin-like 3 Is a Potential Biomarker for Retinopathy in Type 2 Diabetic Patients.
    Yu CG; Yuan SS; Yang LY; Ke J; Zhang LJ; Lang JN; Zhang DW; Zhao SZ; Zhao D; Feng YM
    Am J Ophthalmol; 2018 Jul; 191():34-41. PubMed ID: 29621508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor a in intraocular vascular disease.
    Miller JW; Le Couter J; Strauss EC; Ferrara N
    Ophthalmology; 2013 Jan; 120(1):106-14. PubMed ID: 23031671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular plasticity--the role of the angiopoietins in modulating ocular angiogenesis.
    Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2001 Dec; 239(12):972-5. PubMed ID: 11820705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging roles of angiopoietin-like 4 in human cancer.
    Tan MJ; Teo Z; Sng MK; Zhu P; Tan NS
    Mol Cancer Res; 2012 Jun; 10(6):677-88. PubMed ID: 22661548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiopoietin-Like Protein 4 (ANGPTL4) Induces Retinal Pigment Epithelial Barrier Breakdown by Activating Signal Transducer and Activator of Transcription 3 (STAT3): Evidence from ARPE-19 Cells Under Hypoxic Condition and Diabetic Rats.
    Yang X; Cao J; Du Y; Gong Q; Cheng Y; Su G
    Med Sci Monit; 2019 Sep; 25():6742-6754. PubMed ID: 31494661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiopoietin-like 4 promotes angiogenesis in the tendon and is increased in cyclically loaded tendon fibroblasts.
    Mousavizadeh R; Scott A; Lu A; Ardekani GS; Behzad H; Lundgreen K; Ghaffari M; McCormack RG; Duronio V
    J Physiol; 2016 Jun; 594(11):2971-83. PubMed ID: 26670924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of placental growth factor (PlGF) and its receptor system in retinal vascular diseases.
    Van Bergen T; Etienne I; Cunningham F; Moons L; Schlingemann RO; Feyen JHM; Stitt AW
    Prog Retin Eye Res; 2019 Mar; 69():116-136. PubMed ID: 30385175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current molecular understanding and future treatment strategies for pathologic ocular neovascularization.
    Tolentino MJ
    Curr Mol Med; 2009 Nov; 9(8):973-81. PubMed ID: 19925410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Research Progress on the Involvement of ANGPTL4 and Loss-of-Function Variants in Lipid Metabolism and Coronary Heart Disease: Is the "Prime Time" of ANGPTL4-Targeted Therapy for Coronary Heart Disease Approaching?
    Yang J; Li X; Xu D
    Cardiovasc Drugs Ther; 2021 Jun; 35(3):467-477. PubMed ID: 32500296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ANGIOPOIETIN-LIKE 4 CORRELATES WITH RESPONSE TO INTRAVITREAL RANIBIZUMAB INJECTIONS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Kim JH; Shin JP; Kim IT; Park DH
    Retina; 2018 Mar; 38(3):523-530. PubMed ID: 28151839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of vascular endothelial growth factor in ocular angiogenesis.
    Shams N; Ianchulev T
    Ophthalmol Clin North Am; 2006 Sep; 19(3):335-44. PubMed ID: 16935208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of angiogenic and immunosuppressive factors by uveal melanoma cell lines.
    Ijland SA; Jager MJ; Heijdra BM; Westphal JR; Peek R
    Melanoma Res; 1999 Oct; 9(5):445-50. PubMed ID: 10596910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual role of ANGPTL4 in inflammation.
    Zuo Y; He Z; Chen Y; Dai L
    Inflamm Res; 2023 Jun; 72(6):1303-1313. PubMed ID: 37300585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The eye as a complement dysregulation hotspot.
    Clark SJ; Bishop PN
    Semin Immunopathol; 2018 Jan; 40(1):65-74. PubMed ID: 28948331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Aging and retinal vascular diseases].
    Takagi H
    Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):207-30; discussion 231. PubMed ID: 17402563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ischemic Retinopathies: Oxidative Stress and Inflammation.
    Rivera JC; Dabouz R; Noueihed B; Omri S; Tahiri H; Chemtob S
    Oxid Med Cell Longev; 2017; 2017():3940241. PubMed ID: 29410732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.